Sign in

CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464348039
Phone
617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-05-30 Altmeyer Anne Director Sale 10b5-1 −1,392 $7.25 $10K 1,391
2025-05-30 Altmeyer Anne Director Grant or award 10b5-1 +4,800 6,191
2025-05-30 Altmeyer Anne Director Grant or award · Stock options (right to buy) 10b5-1 +16,000 16,000
2025-05-30 HOLMER ALAN F Director Grant or award +4,800 10,629
2025-05-30 HOLMER ALAN F Director Grant or award · Stock options (right to buy) +16,000 16,000
2025-05-30 Jacques Rachelle Suzanne Director Grant or award +4,800 7,583
2025-05-30 Jacques Rachelle Suzanne Director Grant or award · Stock options (right to buy) +16,000 16,000
2025-03-06 Smethurst Dominic Chief Medical Officer Sale −6,393 $6.78 $43K 70,807
2025-02-14 Moran Sean F. Chief Financial Officer Sale 10b5-1 −2,792 $8.76 $24K 73,313
2025-02-14 Cohen Yuval Chief Executive Officer Sale 10b5-1 −7,134 $8.76 $62K 138,187
2025-01-31 Smethurst Dominic Chief Medical Officer Grant or award +27,200 77,200
2025-01-31 Smethurst Dominic Chief Medical Officer Grant or award · Stock options (right to buy) +91,200 91,200
2025-01-31 Moran Sean F. Chief Financial Officer Grant or award +27,500 76,105
2025-01-31 Moran Sean F. Chief Financial Officer Grant or award · Stock options (right to buy) +92,500 92,500
2025-01-31 Cohen Yuval Chief Executive Officer Grant or award +68,100 145,321
2025-01-31 Cohen Yuval Chief Executive Officer Grant or award · Stock options (right to buy) +228,800 228,800
2024-09-20 Cormorant Asset Management, LP 10% owner Purchase +45,085 $17.48 $788K 2,070,085
2024-09-20 Cormorant Asset Management, LP 10% owner Purchase +25,943 $18.36 $476K 2,096,028
2024-09-20 Cormorant Asset Management, LP 10% owner Purchase +66,088 $19.61 $1.3M 2,162,116
2024-09-20 Cormorant Asset Management, LP 10% owner Purchase +139,551 $20.42 $2.8M 2,301,667

Page 4 of 10 · 200 trades